There is currently no cure for the dystrophinopathies but in the last 10 years several therapeutic approaches aimed at inducing the production of dystrophin protein have been investigated (5). This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.